Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Auterion and maxon collaborating on drones
Zurich - The ETH spin-off Auterion and high-precision motor specialists maxon motor have agreed a partnership. Together, the two companies intend to make the development, operation and fleet management of drones easier and more cost-effective.
Blood test to predict COVID-19
Lugano – The COVID research carried out by the association of hospitals in the canton of Ticino has revealed that blood tests hold the key to identifying severe disease progressions at an early stage. This finding gives medical specialists a decisive time advantage in their efforts to arrange the optimal therapeutic approach for patients.
InSphero and Hamilton Bonaduz agree collaboration
Schlieren ZH/Bonaduz GR - The biotechnology company InSphero has announced a partnership with the lab technology specialists Hamilton Bonaduz. The aim of the collaboration is to improve production and handling of 3D microtissues.
Numab Therapeutics raises 100 million Swiss francs
Wädenswil ZH - Numab Therapeutics has banked 100 million Swiss francs after successfully closing a financing round. The biopharmaceutical firm based in the Greater Zurich Area is focused on producing an immunotherapy to treat cancer. This fresh capital is intended to accelerate the development process.
Rheonics wins award for Flexodruck sensors
Winterthur - Rheonics has won the FTA Technical Innovation Award 2021. With this, the American Flexographic Technical Association (FTA) commended the density and viscosity sensor specialist’s control system to measure ink viscosity in package printing.
Contovista supports artificial intelligence center
Schlieren ZH - Contovista is supporting the Swiss Federal Institute of Technology in Zurich with development of its artificial intelligence center. The FinTech company is bringing its experience in the finance industry to this project.
Cancer cells eliminate themselves
Zurich – Researchers at the University of Zurich have found a way for a tumor to produce therapeutic agents that make it eliminate itself. A virus is modified to act like a Trojan horse and deliver genes for cancer therapeutics directly into the tumor cell, passing the immune system undetected.
Investors accelerate expansion of nexoya
Zurich – New funds will help nexoya expand. The startup has received an investment totaling 1.4 million Swiss francs for its artificial intelligence-based solution for digital marketing campaigns. This will enable nexoya to launch in Germany this summer, before branching out to other European countries.
Antibody effective against mutations
Schlieren ZH - The MTX-COVAB antibody developed by Memo Therapeutics is effective against the original variant of the Sars-CoV-2 virus that causes coronavirus infections as well as the mutations that were first identified in the UK and South Africa. It is now being transferred to the clinical development phase.
Meet with an expansion expert
Is Greater Zurich on your expansion radar? We support you on every step of your expansion journey - from location evaluation to fact finding visits.
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Location evaluation support to find the ideal base for your business
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space
- And much more, customized to meet your needs.